Methotrexate in OA (10.20.2023)
Oct 20, 2023
Dr. Jack Cush discusses the news, journal articles and regulatory actions. This week we discuss JAKne, DLE and SLE and more.
Read Article
Multinational study of 47 studies of 11,085 #RA pts showed the prevalence of ANXIETY to range from 2.4% to 77%. Variance due to inconsistent, non-standardized self-report measures and clinical thresholds. Common; but how common? https://t.co/elcxjfSI7N https://t.co/iRNeQy4pEk
Oct 06, 2023
Residual Disease in Controlled Axial Spondyloarthritis
Aug 16, 2023
Despite being in a state of remission or low disease activity state, in patients with axial spondyloarthritis, up to 42% may still have residual disease.
Read Article
English for the Biologically-Challenged (8.4.2023)
Aug 04, 2023
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. This week highlights Veterans, Vegetarians and Antenatal Corticosteroids.
Read Article
RABBIT Registry Study 2470 pts (1,245 axSpA; 1,225 PsA) - moderate depressive Sxs in 8% & 21% w/ severe Sxs. Depressive Sxs were assoc w/ fatigue, not engaging in sports, & greater functional limitation - may affect perception of disease activity https://t.co/XTyzLF98BC https://t.co/8TLfRBK4lX
Links:
Aug 03, 2023
Unrecognized Mental Health Problems in Autoimmune Diseases
More than half of patients with auto-immune conditions experience mental health conditions such as depression or anxiety, yet most are rarely asked in clinic about mental health symptoms.
https://t.co/wxuGmuPh7D https://t.co/jMZkH1SIcS
Links:
Jul 28, 2023
MMWR: Arthritis Among Children and Adolescents
Jul 21, 2023
The CDC estimates that nearly 220,000 children and adolescents had arthritis during 2017–2021. Prevalence (305 per 100,000) increased with age and is higher in 12–17 year olds; non-Hispanic Black or African Americans; those with anxiety or depression; physically inactive; overweight or a
Read Article
988 -- the new 3 digit Suicide and Crisis Lifeline (available since July 2022). You don't need to be in crisis or suicidal to call 988 and speak with a counselor. It is a free service available at all hours, day or night, for anyone who needs support. https://t.co/RfTfmHbvxJ https://t.co/JPihu6XOyu
Links:
Jul 16, 2023
Why Depression Screening Should be Mandatory at Each Visit
Depression is more widespread than ever in the US, according to a new study from Gallup, showing that 18% of adults are depressed– an increase in 7 percentage points since 2015.
https://t.co/2u82MXIFvb https://t.co/ZpGi4TYdBL
Links:
Jun 16, 2023
High Mortality Rates with Depression in Rheumatoid Arthritis
A Danish cohort study has shown a deadly association between depression and rheumatoid arthritis (RA).
https://t.co/R2MB4bs0Hr https://t.co/rWIfHmBqr8
Links:
Jun 16, 2023
How Often Do You Monitor MTX? (6.16.2023)
Jun 15, 2023
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com, including new drug approval, a new SpA variant and new rules for methotrexate (MTX) monitoring and depression screening.
Read Article
Why Depression Screening Should be Mandatory at Each Visit
Jun 14, 2023
Depression is more widespread than ever in the United States, according to a new study from Gallup, showing that 18% of adults are depressed (or receiving depression treatment for depression) – an increase in 7 percentage points since 2015.
Read Article
High Mortality Rates with Depression in Rheumatoid Arthritis
Jun 14, 2023
A Danish cohort study has shown a deadly association between depression and rheumatoid arthritis (RA).
Using data from the national Danish rheumatologic database, DANBIO, they identified incident RA patients (between 2008 to 2018) and five random non-RA comparators. Drug use (
Read Article
RELIEF Trial: Sublingual Cyclobenzaprine in Fibromyalgia
MedPage Today
May 16, 2023
Fibromyalgia patients hoping to see a more effective and convenient formulation of cyclobenzaprine at their local pharmacies must wait for an ongoing phase III trial -- the product's third -- to finish, as the first two delivered mixed results.
Read Article
Treatment and Management of Neuropsychiatric Lupus
May 02, 2023
On the first day of ACR State of the Art conference in Orlando, Florida, Dr. Michelle Petri reviewed the treatment and management of neuropsychiatric lupus. Dr. Petri, a lupus expert from Johns Hopkins Rheumatology, reviewed the latest clinical and animal model studies that offer hope in
Read Article
National Population Insights (4.28.2023)
Apr 28, 2023
Dr. Jack Cush reviews the news and journal reports and addresses 3 viewer case questions.
Read Article
The Match Game (4.14.2023)
Apr 14, 2023
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com, including Rheumatology success in the NRMP MATCH, Cocaine vasculitis and worrisome safety risks with Biologics and tsDMARDs.
2023 NRMP Match: 365 applicants for Rheum; 97.8% (265 of 271
COVID had a significant effect on mental health of inflammatory rheumatic Dz (IRDs) pts. UK NHS survey of 639 IRD (70% RA, 16% PsA) saw 40% w/ mod/severe pandemic impact on physical & mental health; 29% w/ depression, 22% anxiety; affecting Women>males https://t.co/odUCjScMBZ https://t.co/Eb1E2In5z1
Links:
Apr 13, 2023
Retrospective of 28,360 #PsA pts saw more comorbidities by race - AAs had signif. more HTN (59% vs 52%), DM (31% vs 23%), obesity (47% vs 30%) & gout (12% vs 8%); but whites more cancer (20% vs 16%), anxiety (28% vs 23%), OP(14% vs 12%), more biologic use https://t.co/YwGjVowO3G https://t.co/3BUXFX11rh
Links:
Apr 13, 2023
Pain and Opioid Updates
Apr 13, 2023
Today, the CDC and FDA provided new updates on the scope of pain in the USA and guidance on the use of opioids.
MMWR April 14, 2023
Read Article
Gender Norms in Chronic Pain
EurekAlert!
Apr 06, 2023
Sensitive women and stoical men are the prevalent images of people in chronic pain. Unwarranted differences in medical treatment may result, as a University of Gothenburg doctoral thesis emphasizes.
Approximately a fifth of the Swedish population have long-term pain that can affect
Read Article
Disordered Pain Processing in Fibromyalgia
Apr 05, 2023
Fibromyalgia is a mysterious chronic pain disorder that is difficult to treat. Its causes are also still largely in the dark. A study conducted by the team at the Clinic for Psychosomatic Medicine and Psychotherapy at Ruhr University Bochum, Germany, provides evidence that certain brain areas
Read Article
Joint hypermobility linked to depression & anxiety? Longitudinal Study of 6105 kids at age 14 yrs: 19% had generalised joint hypermobility (more in F) *+& assoc w/ depression (OR: 3.53), anxiety (3.14) at age 18 https://t.co/9NrEfwt4L5 https://t.co/JrM2JKUuJ0
Links:
Dec 09, 2022
We know depression, anxiety are issues for many RA pts. Are we making the diagnosis more?
Olmsted County data:
depression similar over time
anxiety 3x more common in 2005-2014 vs 1985-1994 (adj age/sex +/- others)
How do we address this?
ABST0886 @MayoClinic #ACR22 @RheumNow https://t.co/tzMEE24FZo
Nov 13, 2022
Are we really treating Psoriatic disease if we only address active disease domains and T2T?
Nov 12, 2022
It’s widely accepted that Psoriatic disease has multi-system, multi-domain potential that can lead to life altering complications if left untreated or undertreated. Rheumatologists have shifted the way we discuss treatment options and disease state expectations with patients. Two #ACR22
Read ArticleRecent Blogs
Choice Overload (and the Way Out)
Nov 07, 2023
